Stay updated on TRx0237 in Mild-Moderate Alzheimer's Disease Clinical Trial
Sign up to get notified when there's something new on the TRx0237 in Mild-Moderate Alzheimer's Disease Clinical Trial page.

Latest updates to the TRx0237 in Mild-Moderate Alzheimer's Disease Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now displays a newer revision label (v3.6.6) replacing the previous v3.6.5, signaling a minor update to the page build rather than a change to the study data or content.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe site revision indicator was updated from v3.6.4 to v3.6.5, signaling a minor maintenance update. No trial details or user-facing content is affected.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4. This reflects a minor update to the page's versioning.SummaryDifference0.0%

- Check76 days agoChange Detected- Revision updated from v3.6.0 to v3.6.3, indicating a new site build. This change reflects an underlying software update rather than modifications to the displayed study details.SummaryDifference0.0%

- Check90 days agoChange DetectedRecruitment status is updated to 'No longer looking for participants,' and new sections to help readers navigate and join the study have been added (How to Read a Study Record, Common Questions, How to Join a Study). The labeling of an Interventions/Treatment heading has been updated (Intervention/Treatment) and a site revision note (Revision: v3.6.0) appears.SummaryDifference0.2%

- Check118 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a maintenance update to the page. This change does not modify study content, results, or user-facing information.SummaryDifference0.0%

Stay in the know with updates to TRx0237 in Mild-Moderate Alzheimer's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TRx0237 in Mild-Moderate Alzheimer's Disease Clinical Trial page.